ERYTECH announces ADR Level 1 listing in the US Post author:admERY Post published:January 12, 2015 Post category:Newsroom ERYTECH today announced the launch of a sponsored American Depository Receipt (ADR) Level 1 listing in the United States in order to support the expansion of the Company’s US investor base. You Might Also Like ERYTECH appoints new independent board member March 26, 2015 ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer January 14, 2021 ERYTECH Announces Management Change January 4, 2016
ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer January 14, 2021